Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combined effect of histological findings and diabetes mellitus on liver-related events in patients with metabolic dysfunction-associated steatotic liver disease.
Shiomi A, Miyake T, Furukawa S, Matsuura B, Yoshida O, Watanabe T, Kanamoto A, Miyazaki M, Nakaguchi H, Tokumoto Y, Hirooka M, Abe M, Hiasa Y. Shiomi A, et al. Among authors: nakaguchi h. Hepatol Res. 2024 Apr 24. doi: 10.1111/hepr.14049. Online ahead of print. Hepatol Res. 2024. PMID: 38656764
Fatty liver with metabolic disorder, such as metabolic dysfunction-associated fatty liver disease, indicates high risk for developing diabetes mellitus.
Miyake T, Matsuura B, Furukawa S, Ishihara T, Yoshida O, Miyazaki M, Watanebe K, Shiomi A, Nakaguchi H, Yamamoto Y, Koizumi Y, Tokumoto Y, Hirooka M, Takeshita E, Kumagi T, Abe M, Ikeda Y, Iwata T, Hiasa Y. Miyake T, et al. Among authors: nakaguchi h. J Diabetes Investig. 2022 Jul;13(7):1245-1252. doi: 10.1111/jdi.13772. Epub 2022 Feb 28. J Diabetes Investig. 2022. PMID: 35167194 Free PMC article.
Combined evaluation of Fibrosis-4 index and fatty liver for stratifying the risk for diabetes mellitus.
Todo Y, Miyake T, Furukawa S, Matsuura B, Ishihara T, Miyazaki M, Shiomi A, Nakaguchi H, Kanzaki S, Yamamoto Y, Koizumi Y, Yoshida O, Tokumoto Y, Hirooka M, Takeshita E, Kumagi T, Ikeda Y, Abe M, Iwata T, Hiasa Y. Todo Y, et al. Among authors: nakaguchi h. J Diabetes Investig. 2022 Sep;13(9):1577-1584. doi: 10.1111/jdi.13812. Epub 2022 May 5. J Diabetes Investig. 2022. PMID: 35437902 Free PMC article.
Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis.
Miyake T, Furukawa S, Matsuura B, Yoshida O, Miyazaki M, Shiomi A, Kanzaki S, Nakaguchi H, Sunago K, Nakamura Y, Imai Y, Watanabe T, Yamamoto Y, Koizumi Y, Tokumoto Y, Hirooka M, Kumagi T, Abe M, Hiasa Y. Miyake T, et al. Among authors: nakaguchi h. Biomedicines. 2022 Oct 12;10(10):2540. doi: 10.3390/biomedicines10102540. Biomedicines. 2022. PMID: 36289802 Free PMC article.
Association of abnormal glucose tolerance with liver-related disease and cardiovascular diseases in patients with chronic hepatitis C.
Konishi F, Miyake T, Watanabe T, Tokumoto Y, Furukawa S, Matsuura B, Yoshida O, Miyazaki M, Shiomi A, Kanzaki S, Nakaguchi H, Nakamura Y, Imai Y, Koizumi M, Yamamoto Y, Koizumi Y, Hirooka M, Takeshita E, Kumagi T, Ikeda Y, Abe M, Hiasa Y. Konishi F, et al. Among authors: nakaguchi h. Hepatol Res. 2023 Sep;53(9):806-814. doi: 10.1111/hepr.13925. Epub 2023 Jun 1. Hepatol Res. 2023. PMID: 37183992
Glycemic Control Is Associated with Histological Findings of Nonalcoholic Fatty Liver Disease.
Miyake T, Furukawa S, Matsuura B, Yoshida O, Miyazaki M, Shiomi A, Kanamoto A, Nakaguchi H, Nakamura Y, Imai Y, Koizumi M, Watanabe T, Yamamoto Y, Koizumi Y, Tokumoto Y, Hirooka M, Kumagi T, Takesita E, Ikeda Y, Abe M, Hiasa Y. Miyake T, et al. Among authors: nakaguchi h. Diabetes Metab J. 2024 Feb 2. doi: 10.4093/dmj.2023.0200. Online ahead of print. Diabetes Metab J. 2024. PMID: 38310878 Free article.
Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor.
Konishi K, Miyake T, Furukawa S, Senba H, Kanzaki S, Nakaguchi H, Yukimoto A, Nakamura Y, Watanabe T, Koizumi Y, Yoshida O, Tokumoto Y, Hirooka M, Kumagi T, Abe M, Matsuura B, Hiasa Y. Konishi K, et al. Among authors: nakaguchi h. Atherosclerosis. 2020 Apr;299:32-37. doi: 10.1016/j.atherosclerosis.2020.02.026. Epub 2020 Mar 7. Atherosclerosis. 2020. PMID: 32203743
Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status.
Miyake T, Matsuura B, Furukawa S, Yoshida O, Hirooka M, Kumagi T, Ishihara T, Kanzaki S, Nakaguchi H, Miyazaki M, Nakamura Y, Yamamoto Y, Koizumi Y, Tokumoto Y, Takeshita E, Ikeda Y, Abe M, Kitai K, Hiasa Y. Miyake T, et al. Among authors: nakaguchi h. J Diabetes Investig. 2021 Oct;12(10):1890-1898. doi: 10.1111/jdi.13548. Epub 2021 May 4. J Diabetes Investig. 2021. PMID: 33742744 Free PMC article.
Relationship between body composition and the histology of non-alcoholic fatty liver disease: a cross-sectional study.
Miyake T, Miyazaki M, Yoshida O, Kanzaki S, Nakaguchi H, Nakamura Y, Watanabe T, Yamamoto Y, Koizumi Y, Tokumoto Y, Hirooka M, Furukawa S, Takeshita E, Kumagi T, Ikeda Y, Abe M, Toshimitsu K, Matsuura B, Hiasa Y. Miyake T, et al. Among authors: nakaguchi h. BMC Gastroenterol. 2021 Apr 13;21(1):170. doi: 10.1186/s12876-021-01748-y. BMC Gastroenterol. 2021. PMID: 33849437 Free PMC article.
Additional Effect of Luseogliflozin on Semaglutide in Nonalcoholic Steatohepatitis Complicated by Type 2 Diabetes Mellitus: An Open-Label, Randomized, Parallel-Group Study.
Miyake T, Yoshida O, Matsuura B, Furukawa S, Hirooka M, Abe M, Tokumoto Y, Koizumi Y, Watanabe T, Takeshita E, Sunago K, Yukimoto A, Watanabe K, Miyazaki M, Kanzaki S, Nakaguchi H, Koizumu M, Yamamoto Y, Kumagi T, Hiasa Y. Miyake T, et al. Among authors: nakaguchi h. Diabetes Ther. 2022 May;13(5):1083-1096. doi: 10.1007/s13300-022-01239-7. Epub 2022 Mar 21. Diabetes Ther. 2022. PMID: 35312970 Free PMC article.
71 results